Atlas Trials

Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

Clinical trial NCT00563017 · UNKNOWN

Trial details

NCT number
NCT00563017
Sponsor
Hospital Authority, Hong Kong
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Schizophrenia, CatatonicSchizophrenia, DisorganizedSchizophrenia, ParanoidSchizophreniaPsychotic Disorders
Start date
2004-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.